Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Millendo Therapeutics (MLND) Competitors

Millendo Therapeutics logo

MLND vs. MBX, RVNC, CKPT, AVTE, TSVT, SLRN, CYBN, BIOA, NLTX, and PROC

Should you be buying Millendo Therapeutics stock or one of its competitors? The main competitors of Millendo Therapeutics include MBX Biosciences (MBX), Revance Therapeutics (RVNC), Checkpoint Therapeutics (CKPT), Aerovate Therapeutics (AVTE), 2seventy bio (TSVT), Acelyrin (SLRN), Cybin (CYBN), BioAge Labs (BIOA), Neoleukin Therapeutics (NLTX), and Procaps Group (PROC).

Millendo Therapeutics vs. Its Competitors

MBX Biosciences (NYSE:MBX) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, MBX Biosciences had 1 more articles in the media than Millendo Therapeutics. MarketBeat recorded 1 mentions for MBX Biosciences and 0 mentions for Millendo Therapeutics. MBX Biosciences' average media sentiment score of 1.91 beat Millendo Therapeutics' score of 0.00 indicating that MBX Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
MBX Biosciences Very Positive
Millendo Therapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MBX BiosciencesN/AN/AN/AN/AN/A
Millendo TherapeuticsN/AN/A-$36.41MN/AN/A

MBX Biosciences' return on equity of 0.00% beat Millendo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
MBX BiosciencesN/A N/A N/A
Millendo Therapeutics N/A -91.03%-72.44%

MBX Biosciences currently has a consensus target price of $37.50, indicating a potential upside of 202.42%. Given MBX Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe MBX Biosciences is more favorable than Millendo Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MBX Biosciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Millendo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

MBX Biosciences beats Millendo Therapeutics on 7 of the 7 factors compared between the two stocks.

Get Millendo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLND and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MLND vs. The Competition

MetricMillendo TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$143.20M$799.38M$5.57B$9.02B
Dividend YieldN/A4.84%5.25%4.03%
P/E RatioN/A1.3027.1820.14
Price / SalesN/A227.16417.49184.08
Price / CashN/A23.4437.0657.97
Price / Book4.226.178.085.60
Net Income-$36.41M-$27.58M$3.16B$248.50M

Millendo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLND
Millendo Therapeutics
N/A$7.52
+1.1%
N/A+246.0%$143.20MN/A0.0012
MBX
MBX Biosciences
2.55 of 5 stars
$11.61
+1.8%
$37.50
+223.0%
N/A$388.05MN/A0.0036Positive News
RVNC
Revance Therapeutics
2.7757 of 5 stars
$3.65
flat
$8.45
+131.5%
N/A$381.02M$234.04M-1.89500
CKPT
Checkpoint Therapeutics
0.5333 of 5 stars
$4.26
flat
$4.33
+1.7%
N/A$370.71M$41K-2.3210
AVTE
Aerovate Therapeutics
N/A$9.99
+8.7%
N/A-82.2%$289.56MN/A-3.3420Gap Up
High Trading Volume
TSVT
2seventy bio
N/A$5.00
flat
$5.00
N/A$266.15M$48.37M-2.69440
SLRN
Acelyrin
N/A$2.27
flat
$9.60
+322.9%
N/A$229.17MN/A-0.92135
CYBN
Cybin
2.9265 of 5 stars
$9.00
+7.3%
$86.00
+855.6%
N/A$207.22MN/A-2.0550Analyst Forecast
High Trading Volume
BIOA
BioAge Labs
N/A$4.13
flat
N/AN/A$148.06MN/A0.00N/ANews Coverage
NLTX
Neoleukin Therapeutics
N/A$14.95
-7.5%
N/A-44.9%$140.50MN/A-4.8190High Trading Volume
PROC
Procaps Group
N/A$0.95
-40.3%
N/A-62.2%$107.18M$409.92M0.004,900Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:MLND) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners